awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42201127-0F00C8B6-F0A2-44A1-9620-FB34249DAF9F
Q42201127-0F00C8B6-F0A2-44A1-9620-FB34249DAF9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42201127-0F00C8B6-F0A2-44A1-9620-FB34249DAF9F
Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders.
P2860
Q42201127-0F00C8B6-F0A2-44A1-9620-FB34249DAF9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42201127-0F00C8B6-F0A2-44A1-9620-FB34249DAF9F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2014cd83d2f57fb5fa639f9764a4e997f251fbff
P2860
Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia.